Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s success
Bringing new products to market in the era of outsourced clinical trials is reliant on the ability of sponsors and CROs to work together.
The 2nd annual Clinical Trial Collaborations event
QuintilesIMS’s Cristina Oliva talks to pharmaphorum about her personal highlights from this year’s congress.
Novartis’ phase 3 advanced breast cancer therapy ribociclib shows promise